Jack Nathan Medical Corp.
JNH.V
TSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.17M | -1.38M | 6.08M | 6.11M | 6.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.17M | -1.38M | 6.08M | 6.11M | 6.63M |
| Cost of Revenue | -989.60K | -382.20K | 860.50K | 937.10K | 1.17M |
| Gross Profit | -4.18M | -1.00M | 5.22M | 5.17M | 5.46M |
| SG&A Expenses | -4.18M | -596.30K | 6.45M | 6.66M | 8.05M |
| Depreciation & Amortization | -468.70K | -241.00K | 171.40K | 193.60K | 294.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.64M | -1.22M | 7.48M | 7.79M | 9.51M |
| Operating Income | 475.90K | -163.90K | -1.40M | -1.68M | -2.89M |
| Income Before Tax | 434.60K | -590.20K | -1.58M | -1.76M | -2.79M |
| Income Tax Expenses | -65.30K | -65.30K | 11.30K | 11.30K | 76.60K |
| Earnings from Continuing Operations | 0.50 | -0.52 | -1.59 | -1.78 | -2.27 |
| Earnings from Discontinued Operations | -395.80K | -395.80K | -421.40K | 300.00 | 300.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.53M | 6.51M | 5.02M | 5.26M | -6.20M |
| EBIT | 475.90K | -163.90K | -1.40M | -1.68M | -2.89M |
| EBITDA | 560.40K | 94.80K | -970.30K | -1.08M | -2.16M |
| EPS Basic | 0.09 | 0.07 | 0.06 | 0.06 | -0.07 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| EPS Diluted | 0.08 | 0.07 | 0.06 | 0.06 | -0.07 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 348.40M | 348.40M | 350.76M | 348.40M | 346.83M |
| Average Diluted Shares Outstanding | 357.73M | 357.73M | 360.10M | 357.73M | 355.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |